台股 » 個股 » 神隆 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

神隆

(1789)
可現股當沖
  • 股價
    22.50
  • 漲跌
    ▲0.15
  • 漲幅
    +0.67%
  • 成交量
    377
  • 產業
    上市 生技醫療類股
  • 299人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
神隆 (1789)籌碼相關-致和 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

致和 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/260.222.6000.0022.550.23660.06%
2024/12/13122.7000.0022.2013510.28%
2024/12/0900.00223.4023.40-2334-0.60%
2024/11/29223.4000.0023.4023650.55%
2024/11/2000.00223.5323.60-2374-0.53%
2024/11/1900.00123.2523.25-1371-0.27%
2024/11/1500.00223.2023.05-2375-0.53%
2024/11/1400.00423.1023.00-4373-1.07%
2024/11/13223.1500.0023.3023690.54%
2024/11/06423.6800.0023.5543601.11%
2024/11/0500.00324.1023.95-3351-0.85%
2024/10/2900.00124.2024.10-1393-0.25%
2024/10/28124.4500.0024.4013880.26%
2024/10/23424.3800.0024.3544060.99%
2024/10/22224.4500.0024.5024080.49%
2024/10/1800.00224.7024.65-2436-0.46%
2024/10/16224.5500.0024.4024620.43%
2024/10/081024.7500.0024.85105281.89%
2024/08/2700.00125.3025.30-1862-0.12%
2024/08/26125.6000.0025.7518700.11%
2024/08/1500.00125.5025.20-11,003-0.10%
2024/08/12124.9500.0025.3011,0970.09%
2024/08/0700.00124.8525.10-11,110-0.09%
2024/08/05124.0000.0023.9511,1080.09%
2024/07/300.225.9000.0025.900.21,1140.02%
2024/07/1900.00126.7026.35-11,198-0.08%
2024/07/18126.9000.0026.8511,1880.08%
2024/07/17127.3000.0027.1011,1920.08%
2024/06/2600.000.328.9029.10-0.31,371-0.02%
2024/06/200.228.3500.0028.400.21,4910.01%
2024/06/1900.00128.9028.50-11,490-0.07%
2024/06/14128.8000.0028.8011,5370.07%
2024/06/110.229.2000.0029.200.21,5380.01%
2024/06/070.228.7000.0028.850.21,5080.01%
2024/06/0600.00128.5028.50-11,504-0.07%
2024/06/04128.9000.0028.9011,5120.07%
2024/05/270.228.1000.0028.100.21,4850.01%
2024/05/2400.00128.0528.15-11,482-0.07%
2024/05/23128.6500.0028.3511,4780.07%
2024/05/220.228.6500.0028.650.21,4760.01%
2024/05/2100.00129.5529.35-11,453-0.07%
2024/05/17128.5500.0028.6011,3410.07%
2024/05/1300.00127.7527.60-11,306-0.08%
2024/05/10127.6500.0027.5511,3060.08%
2024/05/0200.00128.9028.65-11,257-0.08%
2024/04/300.228.7000.0028.700.21,2510.01%
2024/04/2400.00127.9027.95-11,158-0.09%
2024/04/23127.9500.0028.0011,1610.09%
2024/04/2200.00227.2527.45-21,154-0.17%
2024/04/180.227.60127.6527.65-0.81,128-0.07%
2024/04/1700.00127.8527.75-11,126-0.09%
2024/04/1600.00127.1026.95-11,118-0.09%
2024/04/12327.5000.0027.4531,0970.27%
2024/04/1000.00228.9828.70-21,040-0.19%
2024/04/090.227.80127.6527.80-0.8985-0.08%
2024/04/0300.00227.5527.75-2919-0.22%
2024/04/02127.6500.0027.6018940.11%
2024/03/220.226.35126.3026.50-0.8679-0.12%
2024/03/21226.359526.3826.40-93674-13.79%
2024/03/20326.68326.2226.7006610.00%
2024/03/18325.5200.0025.4036070.49%
2024/03/159526.1000.0026.109558916.12%
2024/03/0600.00125.3525.25-1572-0.17%
2024/03/0100.00325.3025.25-3583-0.51%
2024/02/23225.15025.0025.1526080.32%
2024/02/2100.000.425.2025.35-0.4608-0.07%
2024/02/1900.00225.7525.55-2614-0.33%
2024/02/0500.00225.4025.40-2619-0.32%
漢達私募引進神隆成第二大股東 攜手拓展改良型新藥Anue鉅亨-2024/12/20
逸達前列腺癌新藥獲美藥證 神隆同步受惠Anue鉅亨-2021/05/27
神隆 相關文章